๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjects

โœ Scribed by B. P. Imbimbo; M. Seiberling; U. Peuckert; G. Hoexter; H. Maier-Lenz; A. Vidi; S. Daniotti


Publisher
Springer
Year
1988
Tongue
English
Weight
448 KB
Volume
35
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacokinetics of fluvoxamine maleate
โœ M. H. De Vries; J. Van Harten; P. Van Bemmel; M. Raghoebar ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 286 KB ๐Ÿ‘ 2 views

The pharmacokinetics of fluvoxamine after single oral administration of 25, 50, and 100mg fluvoxamine maleate was studied in a three-way cross-over study in 12 healthy male subjects. Fluvoxamine was administered orally in a solution. For doseproportionality, AUC, and C,-dose relationships were evalu

Clinical pharmacokinetics and tolerabili
โœ J. H. G. Jonkman; G. Bianchetti; G. Grasmeijer; B. Oosterhuis; J. F. Thiercelin; ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 515 KB

In a double-blind, placebo-controlled, cross-over experiment in 21 healthy male volunteers, aged 19 to 27 y, the pharmacokinetics and tolerance of the new anxiolytic drug alpidem (SL80.0342) and its three major metabolites were studied after single doses of 25, 50, 100 and 200 mg. Plasma concentrati

Pharmacokinetics of moxisylyte in health
โœ F. Bressolle; P. Costa; R. Rouzier-Panis; C. Marquer ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Springer ๐ŸŒ English โš– 390 KB

Objective: The concentration-time profiles of specific metabolites of moxisylyte, an ~-adrenoceptor blocking agent, in the plasma and urine from 18 healthy volunteers were investigated after intracavernous (IC) administrations at three dose levels (10, 20 and 30 mg). Results: Four metabolites, uncon